TABLE 2.
Characteristics of individuals enrolled in this study
| Subject-level characteristic | Value for all subjects (n = 39) |
|---|---|
| Gender (no. [%]) | |
| Female | 15 (51) |
| Male | 14 (49) |
| Race (no. [%]) | |
| Caucasian | 19 (66) |
| Non-Caucasian | 10 (34) |
| Age (median [range]) (yr) | 39 (21–67) |
| HSV status (no. [%]) | |
| HSV-1 seropositive | 29 (100) |
| HSV-2 seropositive | 0 (0) |
| HSV-1 and -2 seropositive | 0 (0) |
| HSV seronegative | 10 (100) |
| HLA status (no. [%]) | |
| HLA-A*02:01 positive | 24 (83) |
| HLA-A*02:01 negative | 5 (17) |
| Herpes disease statusa (no. [%]) | |
| Asymptomatic (ASYMP) | 19 (66) |
| Symptomatic (SYMP) | 10 (34) |
a
Definitions of symptomatic and asymptomatic individuals are detailed in Materials and Methods.